Multidrug-Resistant Gram-Negative Bacteria Infections: Current Epidemiology, Prognosis and Treatment Options
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".
Deadline for manuscript submissions: 20 August 2024 | Viewed by 133
Special Issue Editor
Special Issue Information
Dear Colleagues,
In the rapidly evolving world of infectious diseases, multidrug-resistant Gram-negative bacteria (MDR-GNB) infections present significant threats to global public health. Understanding the prognosis and outcomes of MDR-GNB infections is crucial for healthcare providers and policymakers alike.
In this Special Issue, we welcome scholars to explore current epidemiology, prognosis, and treatment options for these infections, including but not limited to those caused by Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii.
Areas of interest include:
- The latest advances in understanding the mechanisms of resistance and transmission dynamics, as well as novel approaches to combatting these pathogens.
- Evaluation of the efficacy of existing treatment options and the exploration of emerging strategies to effectively prevent and manage these infections.
- Addressing the need for enhanced surveillance and rapid diagnostic methods to monitor the spread of multidrug-resistant Gram-negative bacteria and support optimal clinical decision making in the optimization of treatment plans.
This Special Issue will serve as a valuable resource for clinicians, researchers, and policymakers striving to reduce the impact of drug resistance on global health.
Dr. Novella Carannante
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multidrug-resistant gram-negative bacteria
- epidemiology and prognosis
- antibiotic treatment options
- antimicrobial resistance
- infection control and antibiotic use
